These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10714571)

  • 1. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group.
    Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J
    AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection.
    Van Damme L; Niruthisard S; Atisook R; Boer K; Dally L; Laga M; Lange JM; Karam M; Perriens JH
    AIDS; 1998 Mar; 12(4):433-7. PubMed ID: 9520174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
    Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
    N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa.
    Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z
    AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.
    Richardson BA; Lavreys L; Martin HL; Stevens CE; Ngugi E; Mandaliya K; Bwayo J; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 2001 Jul; 28(7):394-400. PubMed ID: 11460023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
    Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities.
    Vandebosch A; Goetghebeur E; Ramjee G; Alary M; Ettiègne-Traoré V; Chandeying V; Van Damme L;
    Sex Transm Infect; 2004 Jun; 80(3):241-3. PubMed ID: 15170013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S; Joglekar N; Ghate M; Unni J; Risbud A; Bentley M; Shepherd M; Bollinger R; Mehendale S
    Indian J Med Res; 2003 Apr; 117():152-7. PubMed ID: 14604303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world.
    Ramjee G; Morar NS; Alary M; Mukenge-Tshibaka L; Vuylsteke B; Ettiègne-Traoré V; Chandeying V; Karim SA; Van Damme L;
    AIDS; 2000 Nov; 14(16):2553-7. PubMed ID: 11101067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial.
    Martin HL; Stevens CE; Richardson BA; Rugamba D; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK
    Sex Transm Dis; 1997 May; 24(5):279-83. PubMed ID: 9153737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes.
    Ward H; De La Court A; Kitchen V
    Sex Transm Dis; 1996; 23(5):413-4. PubMed ID: 8885074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection.
    Visness CM; Ulin P; Pfannenschmidt S; Zekeng L
    Int J STD AIDS; 1998 Nov; 9(11):695-9. PubMed ID: 9863584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.
    Van Damme L; Ramjee G; Alary M; Vuylsteke B; Chandeying V; Rees H; Sirivongrangson P; Mukenge-Tshibaka L; Ettiègne-Traoré V; Uaheowitchai C; Karim SS; Mâsse B; Perriëns J; Laga M;
    Lancet; 2002 Sep; 360(9338):971-7. PubMed ID: 12383665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda.
    Bakobaki JM; Lacey CJ; Bukenya MI; Nunn AJ; McCormack S; Byaruhanga RN; Okong P; Namukwaya SW; Grosskurth H; Whitworth JA
    AIDS; 2005 Dec; 19(18):2149-56. PubMed ID: 16284465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonoxynol-9 100 mg gel: multi-site safety study from sub-Saharan Africa.
    Hoffman IF; Taha TE; Padian NS; Kelly CW; Welch JD; Martinson FE; Kumwenda NI; Rosenberg ZF; Chilongozi DA; Brown JM; Chirenje M; Richardson BA
    AIDS; 2004 Nov; 18(16):2191-5. PubMed ID: 15577653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an intervention on HIV, sexually transmitted diseases, and condom use among sex workers in Bombay, India.
    Bhave G; Lindan CP; Hudes ES; Desai S; Wagle U; Tripathi SP; Mandel JS
    AIDS; 1995 Jul; 9 Suppl 1():S21-30. PubMed ID: 8561997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-9 film study a blow for microbicide research.
    AIDS Alert; 1997 Jun; 12(6):66-8. PubMed ID: 11364359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
    Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
    Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies.
    Poynten IM; Millwood IY; Falster MO; Law MG; Andresen DN; Van Damme L; Kaldor JM
    AIDS; 2009 Jun; 23(10):1245-54. PubMed ID: 19474652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled Phase II extended safety study of two Invisible Condom formulations in Cameroonian women.
    Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Domingo MC; Giguère JF; Piret J; Mwatha A; Mâsse B; Bergeron MG
    Contraception; 2010 Jan; 81(1):79-85. PubMed ID: 20004278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.